[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Khan et al., 2013 - Google Patents

Gold nanoparticles: a paradigm shift in biomedical applications

Khan et al., 2013

View PDF
Document ID
2444190602358712345
Author
Khan M
Vishakante G
Siddaramaiah H
Publication year
Publication venue
Advances in colloid and interface science

External Links

Snippet

In the medical field, majority of the active ingredients exists in the form of solid particle (90% of all medicines). Nanotechnology had grabbed the attention of many scientists working in different aspects and gave them a vivid imagination in order to utilize the nanotechnology in …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANO-TECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y5/00Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery

Similar Documents

Publication Publication Date Title
Khan et al. Gold nanoparticles: a paradigm shift in biomedical applications
Nejati et al. Biomedical applications of functionalized gold nanoparticles: a review
Gao et al. Gold nanoparticles in cancer theranostics
Lee et al. Simultaneous stabilization and functionalization of gold nanoparticles via biomolecule conjugation: Progress and perspectives
Guo et al. Gold nanoparticles enlighten the future of cancer theranostics
Sztandera et al. Gold nanoparticles in cancer treatment
Chen et al. Structural‐engineering rationales of gold nanoparticles for cancer theranostics
Kairdolf et al. Bioconjugated nanoparticles for biosensing, in vivo imaging, and medical diagnostics
Tam et al. Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications
Cai et al. Applications of gold nanoparticles in cancer nanotechnology
Panchapakesan et al. Gold nanoprobes for theranostics
Gao et al. Applications of nanomaterials inside cells
Chen et al. Gold nanoparticles: from nanomedicine to nanosensing
Li et al. Surface-enhanced Raman nanoparticles for tumor theranostics applications
Liong et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
Liu et al. Cu2–xSe nanocrystals with localized surface plasmon resonance as sensitive contrast agents for in vivo photoacoustic imaging: Demonstration of sentinel lymph node mapping
Marangoni et al. Synthesis, physico-chemical properties, and biomedical applications of gold nanorods—a review
Kim et al. Recent advances in gold nanoparticle-based bioengineering applications
Chauhan et al. Disintegrable NIR light triggered gold nanorods supported liposomal nanohybrids for cancer theranostics
Zhang et al. Gold nanomaterials for oral cancer diagnosis and therapy: advances, challenges, and prospects
Zhang et al. Cell membrane coated smart two-dimensional supraparticle for in vivo homotypic cancer targeting and enhanced combinational theranostics
Ren et al. Preparation, modification, and application of hollow gold nanospheres
Ferreira-Gonçalves et al. Nanogold-based materials in medicine: From their origins to their future
Gao et al. Cellular uptake and intra-organ biodistribution of functionalized silica-coated gold nanorods
Kang et al. Biosafety of inorganic nanomaterials for theranostic applications